Drug intelligence / Profile preview

IDD552

Development stage: Unknown
Modality: Small Molecules

Overview

IDD552 is an experimental small molecule belonging to the class of phenoxyacetic acid derivatives. Its chemical formula is C17H10F4N2O4S and it has a molecular weight of approximately 414.33 g/mol. The compound is referenced in drug discovery databases but has not been approved for any indication and does not have known clinical use or marketed brand names. No detailed mechanism of action or therapeutic target information is publicly available for this compound[1][2][3].

Other names: 5-fluoro-2-({[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)amino]carbonyl}amino)phenoxyacetic acid

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on IDD552.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IDD552.

Explore the full profile